The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
KIR2DL4 (CD158d), an NK Cell-Activating Receptor with Inhibitory Potential
Abstract
KIR2DL4 (CD158d) is an unusual member of the killer cell Ig-like receptor family expressed in all NK cells and some T cells. KIR2DL4 activates the cytotoxicity of NK cells, despite the presence of an immunoreceptor tyrosine-based inhibition motif (ITIM) in its cytoplasmic tail. The role of this ITIM on the activating function of KIR2DL4, and whether it can provide inhibitory signals, is not known. Mutated forms of KIR2DL4 were engineered that lacked either the tyrosine in the ITIM or an arginine-tyrosine motif in the transmembrane region that is required for the activation signal. The activity of the mutated KIR2DL4 molecules was tested in a redirected lysis assay. The ITIM was not necessary for activation of lysis by KIR2DL4. The activation signal of KIR2DL4 was sensitive to inhibition by another ITIM-containing receptor. The activation-deficient mutant of KIR2DL4 inhibited the signal delivered by the activating receptor CD16. In pull-down experiments with GST fusion proteins, the tyrosine-phosphorylated cytoplasmic tail of KIR2DL4 bound the Src homology 2-containing phosphatases 1 and 2, as did the tail of the inhibitory receptor KIR2DL1. Therefore, KIR2DL4 has inhibitory potential in addition to its activating function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA
Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., & Spies, T. (1999) · Science · doi:10.1126/science.285.5428.727 · Cited by 2,999
NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P., & Salazar-Mather, T. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.189 · Cited by 2,113
Activating Receptors and Coreceptors Involved in Human Natural Killer Cell-Mediated Cytolysis
Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., & Moretta, L. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.197 · Cited by 1,778
A Class I Antigen, HLA-G, Expressed in Human Trophoblasts
Kovats, S., Main, E. K., Librach, C., Stubblebine, M., Fisher, S. J., & DeMars, R. (1990) · Science · doi:10.1126/science.2326636 · Cited by 1,407
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
Diefenbach, A., Jensen, E. R., Jamieson, A. M., & Raulet, D. H. (2001) · Nature · doi:10.1038/35093109 · Cited by 1,083
REGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORS
Long, E. O. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.875 · Cited by 939
Self-citationKlingmüller, U., Lorenz, U., Cantley, L. C., Neel, B. G., & Lodish, H. F. (1995) · Cell · doi:10.1016/0092-8674(95)90351-8 · Cited by 929
Valiante, N. M., Uhrberg, M., Shilling, H. G., Lienert-Weidenbach, K., Arnett, K. L., D'Andrea, A., Phillips, J. H., Lanier, L. L., & Parham, P. (1997) · Immunity · doi:10.1016/s1074-7613(00)80393-3 · Cited by 732
Rajagopalan, S., & Long, E. O. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1093 · Cited by 726
Self-citationRecruitment of Tyrosine Phosphatase HCP by the Killer Cell Inhibitory Receptor
Burshtyn, D. N., Scharenberg, A. M., Wagtmann, N., Rajagopalan, S., Berrada, K., Yi, T., Kinet, J.-P., & Long, E. O. (1996) · Immunity · doi:10.1016/s1074-7613(00)80300-3 · Cited by 613
Self-citationCerwenka, A., Baron, J. L., & Lanier, L. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201238598 · Cited by 606
HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance
Paul, P., Rouas-Freiss, N., Khalil-Daher, I., Moreau, P., Riteau, B., Le Gal, F. A., Avril, M. F., Dausset, J., Guillet, J. G., & Carosella, E. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4510 · Cited by 432
IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes
Moreau, P., Adrian-Cabestre, F., Menier, C., Guiard, V., Gourand, L., Dausset, J., Carosella, E. D., & Paul, P. (1999) · International Immunology · doi:10.1093/intimm/11.5.803 · Cited by 411
Ponte, M., Cantoni, C., Biassoni, R., Tradori-Cappai, A., Bentivoglio, G., Vitale, C., Bertone, S., Moretta, A., Moretta, L., & Mingari, M. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5674 · Cited by 364
On guard—activating NK cell receptors
Lanier, L. L. (2001) · Nature Immunology · doi:10.1038/83130 · Cited by 346
Wagtmann, N., Rajagopalan, S., Winter, C. C., Peruui, M., & Long, E. O. (1995) · Immunity · doi:10.1016/1074-7613(95)90069-1 · Cited by 335
Self-citationPende, D., Cantoni, C., Rivera, P., Vitale, M., Castriconi, R., Marcenaro, S., Nanni, M., Biassoni, R., Bottino, C., Moretta, A., et al. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200104)31:4<1076::aid-immu1076>3.0.co;2-y · Cited by 334
Riteau, B., Rouas-Freiss, N., Menier, C., Paul, P., Dausset, J., & Carosella, E. D. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.5018 · Cited by 324
Rapid Evolution of NK Cell Receptor Systems Demonstrated by Comparison of Chimpanzees and Humans
Khakoo, S. I., Rajalingam, R., Shum, B. P., Weidenbach, K., Flodin, L., Muir, D. G., Canavez, F., Cooper, S. L., Valiante, N. M., Lanier, L. L., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)80219-8 · Cited by 277
Rajagopalan, S., Fu, J., & Long, E. O. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.1877 · Cited by 258
Self-citationKing, A. (1998) · Human Reproduction Update · doi:10.1093/humupd/4.5.480 · Cited by 210
Fry, A. M., Lanier, L. L., & Weiss, A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.1.295 · Cited by 208
Campbell, K. S., Dessing, M., Lopez-Botet, M., Cella, M., & Colonna, M. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.1.93 · Cited by 205
Long, E. O., Barber, D. F., Burshtyn, D. N., Faure, M., Peterson, M., Rajagopalan, S., Renard, V., Sandusky, M., Stebbins, C. C., Wagtmann, N. R., et al. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1810119.x · Cited by 146
Self-citationFassett, M., Davis, D., Valter, M., Cohen, G. B., & Strominger, J. (2001) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.211563598 · Cited by 138
Yusa, S.-I., Catina, T. L., & Campbell, K. S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.5047 · Cited by 132
Diversity of the Killer Cell Ig-Like Receptors of Rhesus Monkeys
Hershberger, K. L., Shyam, R., Miura, A., & Letvin, N. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4380 · Cited by 124
Selvakumar, A., Steffens, U., & Dupont, B. (1996) · Tissue Antigens · doi:10.1111/j.1399-0039.1996.tb02647.x · Cited by 119
Bruhns, P., Marchetti, P., Fridman, W. H., Vivier, É., & Daëron, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3168 · Cited by 119
HLA-G and HLA-E: fundamental and pathophysiological aspects
Carosella, E. D., Paul, P., Moreau, P., & Rouas‐Freiss, N. (2000) · Immunology Today · doi:10.1016/s0167-5699(00)01707-2 · Cited by 117
New nomenclature for MHC receptors
André, P., Biassoni, R., Colonna, M., Cosman, D. J., Lanier, L. L., Long, E. O., López‐Botet, M., Moretta, A., Moretta, L., Parham, P., et al. (2001) · Nature Immunology · doi:10.1038/90589 · Cited by 111
Self-citationBruhns, P., Vely, F., Malbec, O., Fridman, W. H., Vivier, É., & Daëron, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003518200 · Cited by 103
Watzl, C., Stebbins, C. C., & Long, E. O. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.7.3545 · Cited by 102
Self-citationRajalingam, R., Hong, M., Adams, E. J., Shum, B. P., Guethlein, L. A., & Parham, P. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.1.135 · Cited by 98
Regulation through inhibitory receptors: Lessons from natural killer cells.
Burshtyn, D., & Long, E. O. (1997) · Trends in Cell Biology · doi:10.1016/s0962-8924(97)01167-7 · Cited by 97
Self-citationBurshtyn, D. N., Lam, A. S., Weston, M., Gupta, N., Warmerdam, P. A. M., & Long, E. O. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.2.897 · Cited by 85
Self-citationBinding of src-like Kinases to the β-Subunit of the Interleukin-3 Receptor
Burton, E. A., Hunter, S., Wu, S. C., & Anderson, S. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16189 · Cited by 41
Bischof, A. (2000) · doi:10.1002/1521-4141(200003)30:3
Cited by
Lanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769
MHC class I molecules and kirs in human history, health and survival
Parham, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1570 · Cited by 1,203
Activation, coactivation, and costimulation of resting human natural killer cells
Bryceson, Y. T., March, M. E., Ljunggren, H., & Long, E. O. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00457.x · Cited by 650
Self-citationActivating and inhibitory receptors of natural killer cells
Pegram, H. J., Andrews, D. M., Smyth, M. J., Darcy, P. K., & Kershaw, M. H. (2011) · Immunology & Cell Biology · doi:10.1038/icb.2010.78 · Cited by 555
Ganesan, A.-P., Clarke, J., Wood, O., Garrido-Martin, E. M., Chee, S. J., Mellows, T., Samaniego-Castruita, D., Singh, D., Seumois, G., Alzetani, A., et al. (2017) · Nature Immunology · doi:10.1038/ni.3775 · Cited by 528
Metadata
- Authors
- Faure, M., & Long, E. O.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-06
- Volume
- 168
- Issue
- 12
- Pages
- 6208-6214
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2104689649
- Cited by
- 268
- References
- 38
- FWCI
- 4.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.